Seres Therapeutics, Inc. (MCRB): Price and Financial Metrics

MCRB POWR Grades

• MCRB scores best on the Value dimension, with a Value rank ahead of 89.2% of US stocks.
• The strongest trend for MCRB is in Value, which has been heading up over the past 179 days.
• MCRB ranks lowest in Momentum; there it ranks in the 4th percentile.

MCRB Stock Summary

• Price to trailing twelve month operating cash flow for MCRB is currently 102.77, higher than 95.66% of US stocks with positive operating cash flow.
• Revenue growth over the past 12 months for Seres Therapeutics Inc comes in at 336.33%, a number that bests 97.61% of the US stocks we're tracking.
• In terms of volatility of its share price, MCRB is more volatile than 96.53% of stocks we're observing.
• Stocks that are quantitatively similar to MCRB, based on their financial statements, market capitalization, and price volatility, are AGLE, CHRS, CRIS, FUSN, and VYGR.
• Visit MCRB's SEC page to see the company's official filings. To visit the company's web site, go to www.serestherapeutics.com.

MCRB Valuation Summary

• MCRB's price/sales ratio is 19.6; this is 415.79% higher than that of the median Healthcare stock.
• MCRB's price/earnings ratio has moved up 73.9 over the prior 75 months.
• MCRB's EV/EBIT ratio has moved up 76.6 over the prior 75 months.

Below are key valuation metrics over time for MCRB.

MCRB Growth Metrics

Its 3 year revenue growth rate is now at 1066.68%.
• Its 5 year cash and equivalents growth rate is now at -71.83%.
• The year over year net cashflow from operations growth rate now stands at -44.57%.

Over the past 70 months, MCRB's revenue has gone up $142,217,000.

The table below shows MCRB's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	144.927	6.688	-65.578
2021-09-30	155.27	40.624	-33.829
2021-06-30	29.962	-112.984	-132.327
2021-03-31	30.744	-98.855	-104.711
2020-12-31	33.215	-93.61	-89.127
2020-09-30	23.273	-89.73	-89.653

MCRB's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• MCRB has a Quality Grade of C, ranking ahead of 46.12% of graded US stocks.
• MCRB's asset turnover comes in at 0.094 -- ranking 268th of 680 Pharmaceutical Products stocks.
• ABEO, VXRT, and ARWR are the stocks whose asset turnover ratios are most correlated with MCRB.

The table below shows MCRB's key quality metrics over time.